Skip to content

Machine Learning-based Surgical Guidance System for Robot-assisted Rectal Surgery

Machine Learning-based Surgical Guidance System for Robot-assisted Rectal Surgery - a First-in-human Interventional Study

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05652361
Acronym
CoBot2
Enrollment
12
Registered
2022-12-15
Start date
2026-02-25
Completion date
2027-12-01
Last updated
2026-08-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Rectum Cancer

Keywords

Robotic Surgery, Total mesorectal excision

Brief summary

The aim of the study is to evaluate the technical feasibility and applicability of a surgical assistance system based on image recognition algorithms in a first-in-human pilot study. In addition, this study will provide preliminary data on the oncological outcome of the assistance system.

Interventions

OTHERAdditional visualisation of surgical assistance during surgery

Robot-assisted anterior rectal resection using daVinci® system as CE-marked gold standard with additional visualization of surgical assistance functions based on machine learning techniques

Sponsors

Technische Universität Dresden
Lead SponsorOTHER
German Cancer Research Center
CollaboratorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
OTHER
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patients with rectal cancer scheduled for robot-assisted rectal resection * Intact preoperative urogenital/rectal function * Full capability of consent

Exclusion criteria

* Previous/Second malignant disease \<5 years before diagnosis of rectal cancer * Previous abdominal surgery, except for laparoscopic appendectomy, laparoscopic cholecystectomy or Cesarean section * Pregnant or breastfeeding women * Addiction or illness that prevent the person concerned from assessing the nature and scope of the clinical trial and its possible consequences * indication that the participant is unlikely to comply with the trial protocoll (e.g. lack of compliance) * official or court order for involuntary hospitalization

Design outcomes

Primary

MeasureTime frameDescription
Incidence of discrepancies between the surgeon's preparation and the prediction of the CoBot system72 hours after SurgerySystem discrepancy score quantifying major misspecifications of the CoBot system in comparison to the surgeon's action

Secondary

MeasureTime frameDescription
Operating time [min]During SurgeryTime from skin incision until placement of last skin staple/suture
Duration of postoperative hospital stay [days]At day of discharge, assessed up to 5 daysPostoperative day 1 until day of discharge
Duration of postoperative intermediate/intensive care unit stay [days]At day of discharge, assessed up to 5 daysPostoperative day 1 until day of discharge
Frequency of peri-operative morbidity after resectionAt day of discharge, assessed of up to 5 daysFrequency of peri-operative complications after surgery until Day of Discharge
Kind of peri-operative morbidity after resectionAt day of discharge, assessed of up to 5 daysKind of peri-operative complications after surgery until day of discharge
Assessment of the circumferential resection margin (CRM)At day of discharge, assessed up to 5 daysRate of R0 resections
Number of resected lymphnodesDuring surgeryNumber of lymphnodes resected during surgery
Assessment of pelvic function before and after rectal resection15 monthsRectal function will be assessed preoperatively and 12-15 months postoperatively using the standard LARS score questionnaire, resulting in a score between 0 and 42. Higher scores mean a worse outcome (worse pelvic function).
Rectal sphincter function before and after rectal resection15 monthsSphincter function will be assessed by manometry preoperatively and 12 - 15 months postoperatively
Assessment of the difficulty of the preparation48 hours after surgerySurgeon questionnaire, the questionnaire qualitatively assesses nine items, each item scoring from "not at all" to "very much", evaluated individually
Assessment of usability of guidance systemThrough study completion, an average of 6 monthsOne-time final survey of all participating surgeons, the questionnaire qualitatively assesses nine items, each item scoring from "not at all" to "very much", evaluated individually

Countries

Germany

Contacts

CONTACTMarius Distler, Prof. Dr.
marius.distler@ukdd.de+49 351 458 4098
CONTACTFiona Kolbinger, Dr.
fiona.kolbinger@ukdd.de+49 351 458 4098
PRINCIPAL_INVESTIGATORMarius Distler, Prof. Dr.

University Hospital Carl Gustav Carus Dresden

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Aug 28, 2026